1-3 of 3
Dexiang Ji
Close
Sort by
Journal Articles

Efficacy and Safety of CD19-Specific CAR-T Cell Therapy Following Immunochemotherapy in Newly Diagnosed B-Cell Lymphoma Associated Hemophagocytic Lymphohistiocytosis

Yulan Zhou, Yulong Jin, Dexiang Ji, Fancong Kong, Yu Peng, Min Yu, Shixuan Wang, Xiaoye Cheng, Fei Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 4843.
https://doi.org/10.1182/blood-2023-189192
Published: 2023
Journal Articles

Safety, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Adult Patients with Primary Immune Thrombocytopenia: A Randomized, Double-Blind and Placebo-Controlled Phase 1b Study

Renchi Yang, Hu Zhou, Yu Hu, Jie Yin, Junmin Li, Wenming Chen, Ruibin Huang, Yuping Gong, Chenwei Luo, Liu Xiaofan, Heng Mei, Bingjie Ding, Chengyuan Gu, Huiping Sun, Leng Yun, Dexiang Ji, Yan Li, Haiyan Shi, Hongyan Yin, Songhua Fan, Jian Wang, Weiguo Su
Journal: Blood
Blood (2021) 138 (Supplement 1): 16.
https://doi.org/10.1182/blood-2021-149895
Published: 2021
Journal Articles

Real-World Effectiveness and Safety of Eltrombopag in Patients with Aplastic Anemia: A Chinese Nationwide Survey

Wenrui Yang, MD, Bing Han, MD PhD, Hong Chang, MD, Bingyi Wu, MD, Fankai Meng, Dexiang Ji, MD, Yingmei Li, MD, Zhengjin Zheng, MD, Yan Fei, Jianping Shen, MD, Ping Hu, MD, Jianxiang Wang, MD, Fengkui Zhang, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5020.
https://doi.org/10.1182/blood-2019-126441
Published: 2019